- Home
- HKPD vs PMN Comparison
HKPD vs PMN Comparison
Compare HKPD & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKPD
- PMN
- Stock Information
- Founded
- HKPD 2016
- PMN 2004
- Country
- HKPD Hong Kong
- PMN Canada
- Employees
- HKPD N/A
- PMN N/A
- Industry
- HKPD Other Pharmaceuticals
- PMN Pharmaceuticals and Biotechnology
- Sector
- HKPD Health Care
- PMN Health Care
- Exchange
- HKPD Nasdaq
- PMN Nasdaq
- Market Cap
- HKPD 20.9M
- PMN 22.3M
- IPO Year
- HKPD 2025
- PMN N/A
- Fundamental
- Price
- HKPD $1.34
- PMN $0.55
- Analyst Decision
- HKPD
- PMN Strong Buy
- Analyst Count
- HKPD 0
- PMN 3
- Target Price
- HKPD N/A
- PMN $4.33
- AVG Volume (30 Days)
- HKPD 333.5K
- PMN 736.2K
- Earning Date
- HKPD 08-14-2025
- PMN 11-13-2025
- Dividend Yield
- HKPD N/A
- PMN N/A
- EPS Growth
- HKPD N/A
- PMN N/A
- EPS
- HKPD N/A
- PMN N/A
- Revenue
- HKPD $20,313,818.00
- PMN N/A
- Revenue This Year
- HKPD N/A
- PMN N/A
- Revenue Next Year
- HKPD N/A
- PMN N/A
- P/E Ratio
- HKPD N/A
- PMN N/A
- Revenue Growth
- HKPD 21.72
- PMN N/A
- 52 Week Low
- HKPD $0.81
- PMN $0.38
- 52 Week High
- HKPD $3.79
- PMN $1.59
- Technical
- Relative Strength Index (RSI)
- HKPD 48.60
- PMN 62.79
- Support Level
- HKPD $1.51
- PMN $0.39
- Resistance Level
- HKPD $1.52
- PMN $0.45
- Average True Range (ATR)
- HKPD 0.15
- PMN 0.03
- MACD
- HKPD -0.02
- PMN 0.02
- Stochastic Oscillator
- HKPD 23.81
- PMN 89.16
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.